In particular, the IDH1 gene shows a Y272C somatic variant; this gene is known to be frequently mutated in glioma, cholangiocarcinoma, chondrosarcoma, and acute myeloid leukemia, but in those diseases the recurrent mutations is a gain-of-function point mutation at arginine 132. Here, IDH1 is linked to cholangiocarcinoma.